defense procurement
Henley-Putnam University

Osiris Therapeutics wins contract for development of radiation treatment

January 4, 2008 @ 3:14 pm · Filed under Department of Defense, Osiris Therapuetics, development program, medicine

The Department of Defense awarded Osiris Therapuetics a contract that might be worth $224 M dollars to utilize a stem-cell therapy drug to treat radiation caused gastrointestinal injuries. See CNNMoney.com story here. The initial funding of $4 M is to develop the treatment, with another $200 M possible if the DoD decides to purchase units. This is an example of how diverse DoD spending is. It is not just for bullets, beans, gas and soldiers.

2 Comments »

  1. Cleveland BioLabs Loses Out to Osiris For Radiation Treatment Contract | Defense Procurement News Said,

    January 4, 2008 @ 10:38 pm

    [...] we reported earlier today, Osiris Therapeutics won a Department of Defense contract to develop a treatment for radiation [...]

  2. Osiris defense contract makes company take off | Defense Procurement News Said,

    January 12, 2008 @ 6:25 am

    [...] gastrointestinal system has really caused the company and its stock to take off. See previous posts here and here for more detail. The contract could be worth $225 M initially, and if the US Government [...]

RSS feed for comments on this post · TrackBack URI

Leave a Comment

You must be logged in to post a comment.